Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy

Author： Leitao M.M. Hummer A. Dizon D.S. Aghajanian C. Hensley M. Sabbatini P. Venkatraman E. Spriggs D.R.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.91, Iss.1, 2003-10, pp. : 123-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activity of Gemcitabine in Platinum-resistant Ovarian Germ Cell Cancer

By Maas K. Daikeler T. Kanz L. Bokemeyer C.

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1437-1438

Elsevier

Access to resources Recommend Favorite

A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer

By Westermann A.M. Grosen E.A. Katschinski D.M. Jager D. Rietbroek R. Schink J.C. Tiggelaar C.L. Jager E. Zum Vorde sive Vording P. Neuman A. Knuth A. Van Dijk J.D.P. Wiedemann G.J. Robins H.I.

European Journal of Cancer, Vol. 37, Iss. 9, 2001-06 ,pp. : 1111-1117

Elsevier

Access to resources Recommend Favorite

Platinum-Resistant and Refractory Ovarian Cancer: Second-Line Treatment Options

By Alvarez A.A. Clarke-Pearson D.L.

American Journal of Cancer, Vol. 2, Iss. 1, 2003-01 ,pp. : 1-13

Adis International

Access to resources Recommend Favorite

Altretamine (Hexamethylmelamine) in Platinum-Resistant and Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Phase II Trial

By Markman M. Blessing J.A. Moore D. Ball H. Lentz S.S.

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 226-229

Elsevier

Access to resources Recommend Favorite

Evaluation of Cisplatin and Cyclosporin A in Recurrent Platinum-Resistant Ovarian Cancer: A Phase II Study of the Gynecologic Oncology Group

By Manetta A. Blessing J.A. Hurteau J.A.

Gynecologic Oncology, Vol. 68, Iss. 1, 1998-01 ,pp. : 45-46

Elsevier

Access to resources Recommend Favorite